Lunit announced a partnership with a leading PACS provider INFINITT Healthcare to accelerate its global expansion. Lunit and INFINITT Healthcare recently entered into a global software distribution and licensing partnership. Implemented in the INFINITT PACS system, Lunit AI will be distributed in the global market and expand its market presence.

INFINITT Healthcare is a dominant player in the South Korean PACS market, globally recognized for its technology. As the first step, the two companies signed their first commercial sales contract with Leuwiliang General Hospital in Indonesia. Leuwiliang General Hospital is one of the leading healthcare institutions of West Java Indonesia that provide diagnosis and treatment of COVID-19 patients.

West Java is also known as the region with the second most cases following Jakarta. The number of COVID-19 cases have rapidly increased in Indonesia since the end of last year, with more than one million new cases confirmed everyday. Lunit INSIGHT CXR is now supporting medical professionals to diagnose COVID-19 in more than 10 countries and has an accuracy of 97 to 99% in detecting 10 major chest diseases such as lung nodules and pneumothorax.

It is CE marked and clinically available in Europe, Middle East, Latin America, South East Asia, Australia, and New Zealand.